The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against the usage of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases affecting the testes, pituitary and hypothalamus, it has not been approved
for treating age-related decrease in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study included about 800 elderly men with low testosterone and symptoms associated with this condition, for example testosterone therapy for females
sexual and physical dysfunction. The research is expected to shed more light on the security of testosterone treatment, since the men's heart health was carefully monitored.
The recent conflicting findings on testosterone treatment prompted Patel and his team to run a large systematic literature search for studies evaluating the relationship between testosterone replacement therapy and cardiovascular events among guys. An estimated 13 million men in the USA have problems with low testosterone, which happens when the body doesn't make enough hormones because of a problem with the testicles or pituitary gland. This clarifies apparent aging, a person's unexpected weight gain and loss of energy.
And many girls have a knee jerk feeling that any hormone treatment
can raise their risk of breast cancer. However, clinical studies show that testosterone not only does not raise a woman's risk of breast cancer , it may play a key role in warding off the disease. Glaser thinks this will probably remain the status quo for a while, given the prohibitive cost of running the long-term safety studies needed to acquire fuller FDA acceptance.